Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2062 | 5292 | 34.5 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
2062 | 2 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//ENDOCAN | 5292 |
639 | 1 | VON WILLEBRAND DISEASE//VON WILLEBRAND FACTOR//VWD | 3220 |
16397 | 1 | THROMBOSTAT//BLEEDING TIME//COAGULAT SERV THROMBOSIS | 655 |
19322 | 1 | ACQUIRED VON WILLEBRAND SYNDROME//ACQUIRED VON WILLEBRAND DISEASE//HEMOSTASIS HEMATOL | 511 |
22060 | 1 | DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN | 395 |
31160 | 1 | VB 111//MOL VASC MED//ADV STUDIES PHARMACOBIOL | 157 |
31261 | 1 | WEIBEL PALADE BODIES//TOAD AORTA//SANQUIN AMC LANDSTEINER | 155 |
32333 | 1 | ENDOCAN//ENDOTHELIAL CELL SPECIFIC MOLECULE 1//ESM 1 | 140 |
37394 | 1 | SCUBE1//SIGNAL PEPTIDE CUB EGF DOMAIN CONTAINING PROTEIN 1//SCUBE3 | 59 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VON WILLEBRAND DISEASE | authKW | 3692925 | 16% | 78% | 825 |
2 | VON WILLEBRAND FACTOR | authKW | 1540975 | 15% | 33% | 805 |
3 | ENDOCAN | authKW | 404468 | 1% | 89% | 79 |
4 | VWD | authKW | 353284 | 1% | 88% | 70 |
5 | DESMOPRESSIN | authKW | 280788 | 3% | 28% | 177 |
6 | ACQUIRED VON WILLEBRAND SYNDROME | authKW | 247858 | 1% | 73% | 59 |
7 | DDAVP | authKW | 245812 | 2% | 47% | 90 |
8 | WEIBEL PALADE BODIES | authKW | 207194 | 1% | 56% | 64 |
9 | HEMATOLOGY | WoSSC | 163178 | 53% | 1% | 2817 |
10 | RISTOCETIN COFACTOR ACTIVITY | authKW | 163031 | 1% | 91% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 163178 | 53% | 1% | 2817 |
2 | Peripheral Vascular Diseases | 31414 | 23% | 0% | 1214 |
3 | Urology & Nephrology | 791 | 4% | 0% | 228 |
4 | Medicine, Research & Experimental | 688 | 5% | 0% | 287 |
5 | Medicine, General & Internal | 534 | 6% | 0% | 336 |
6 | Medical Laboratory Technology | 360 | 2% | 0% | 86 |
7 | Transplantation | 144 | 1% | 0% | 79 |
8 | Anesthesiology | 125 | 1% | 0% | 67 |
9 | Pathology | 113 | 2% | 0% | 108 |
10 | Pediatrics | 104 | 3% | 0% | 138 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEMOSTASIS THROMBOSIS SCI | 75369 | 0% | 93% | 14 |
2 | U143 | 62483 | 1% | 31% | 35 |
3 | ANGELO BIANCHI BONOMI HEMOPHILIA THROMBOSIS | 51121 | 1% | 15% | 61 |
4 | ROON ARTERIOSCLEROSIS THROMBOSIS | 49116 | 1% | 30% | 28 |
5 | WSAHS | 46137 | 0% | 67% | 12 |
6 | HEMOPHILIA THROMBOSIS | 43660 | 1% | 21% | 36 |
7 | U770 | 39627 | 1% | 25% | 28 |
8 | EXPTL HEMOSTASIS THROMBOSIS | 36044 | 0% | 63% | 10 |
9 | WOMENS HEMOSTASIS THROMBOSIS CLIN | 35328 | 0% | 88% | 7 |
10 | JON J VAN ROOD CLIN TRANSFUS MED | 34609 | 0% | 100% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HAEMOPHILIA | 123547 | 5% | 8% | 257 |
2 | THROMBOSIS AND HAEMOSTASIS | 83812 | 7% | 4% | 381 |
3 | THROMBOSIS RESEARCH | 45196 | 5% | 3% | 284 |
4 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 43438 | 3% | 4% | 172 |
5 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 39038 | 3% | 5% | 134 |
6 | BLOOD | 29672 | 8% | 1% | 423 |
7 | BLOOD COAGULATION & FIBRINOLYSIS | 16051 | 2% | 3% | 96 |
8 | AMERICAN JOURNAL OF HEMATOLOGY | 12900 | 2% | 2% | 116 |
9 | HAEMOSTASIS | 12530 | 1% | 4% | 52 |
10 | BRITISH JOURNAL OF HAEMATOLOGY | 11993 | 3% | 1% | 169 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VON WILLEBRAND DISEASE | 3692925 | 16% | 78% | 825 | Search VON+WILLEBRAND+DISEASE | Search VON+WILLEBRAND+DISEASE |
2 | VON WILLEBRAND FACTOR | 1540975 | 15% | 33% | 805 | Search VON+WILLEBRAND+FACTOR | Search VON+WILLEBRAND+FACTOR |
3 | ENDOCAN | 404468 | 1% | 89% | 79 | Search ENDOCAN | Search ENDOCAN |
4 | VWD | 353284 | 1% | 88% | 70 | Search VWD | Search VWD |
5 | DESMOPRESSIN | 280788 | 3% | 28% | 177 | Search DESMOPRESSIN | Search DESMOPRESSIN |
6 | ACQUIRED VON WILLEBRAND SYNDROME | 247858 | 1% | 73% | 59 | Search ACQUIRED+VON+WILLEBRAND+SYNDROME | Search ACQUIRED+VON+WILLEBRAND+SYNDROME |
7 | DDAVP | 245812 | 2% | 47% | 90 | Search DDAVP | Search DDAVP |
8 | WEIBEL PALADE BODIES | 207194 | 1% | 56% | 64 | Search WEIBEL+PALADE+BODIES | Search WEIBEL+PALADE+BODIES |
9 | RISTOCETIN COFACTOR ACTIVITY | 163031 | 1% | 91% | 31 | Search RISTOCETIN+COFACTOR+ACTIVITY | Search RISTOCETIN+COFACTOR+ACTIVITY |
10 | INHERITED BLEEDING DISORDERS | 149281 | 1% | 54% | 48 | Search INHERITED+BLEEDING+DISORDERS | Search INHERITED+BLEEDING+DISORDERS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NICHOLS, WL , HULTIN, MB , JAMES, AH , MANCO-JOHNSON, MJ , MONTGOMERY, RR , ORTEL, TL , RICK, ME , SADLER, JE , WEINSTEIN, M , YAWN, BP , (2008) VON WILLEBRAND DISEASE (VWD): EVIDENCE-BASED DIAGNOSIS AND MANAGEMENT GUIDELINES, THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) EXPERT PANEL REPORT (USA).HAEMOPHILIA. VOL. 14. ISSUE 2. P. 171 -232 | 257 | 77% | 290 |
2 | NICHOLS, WC , GINSBURG, D , (1997) VON WILLEBRAND DISEASE.MEDICINE. VOL. 76. ISSUE 1. P. 1-20 | 194 | 94% | 106 |
3 | KEENEY, S , CUMMING, AM , (2001) THE MOLECULAR BIOLOGY OF VON WILLEBRAND DISEASE.CLINICAL AND LABORATORY HAEMATOLOGY. VOL. 23. ISSUE 4. P. 209 -230 | 180 | 95% | 28 |
4 | SADLER, JE , BUDDE, U , EIKENBOOM, JCJ , FAVALORO, EJ , HILL, FGH , HOLMBERG, L , INGERSLEV, J , LEE, CA , LILLICRAP, D , MANNUCCI, M , ET AL (2006) UPDATE ON THE PATHOPHYSIOLOGY AND CLASSIFICATION OF VON WILLEBRAND DISEASE: A REPORT OF THE SUBCOMMITTEE ON VON WILLEBRAND FACTOR.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 4. ISSUE 10. P. 2103 -2114 | 96 | 96% | 418 |
5 | MIKHAIL, S , ALDIN, ES , STREIFF, M , ZEIDAN, A , (2014) AN UPDATE ON TYPE 2B VON WILLEBRAND DISEASE.EXPERT REVIEW OF HEMATOLOGY. VOL. 7. ISSUE 2. P. 217-231 | 129 | 86% | 1 |
6 | SADLER, JE , MANNUCCI, PM , BERNTORP, E , BOCHKOV, N , BOULYJENKOV, V , GINSBURG, D , MEYER, D , PEAKE, I , RODEGHIERO, F , SRIVASTAVA, A , (2000) IMPACT, DIAGNOSIS AND TREATMENT OF VON WILLEBRAND DISEASE.THROMBOSIS AND HAEMOSTASIS. VOL. 84. ISSUE 2. P. 160 -174 | 130 | 87% | 269 |
7 | FAVALORO, EJ , (2014) DIAGNOSING VON WILLEBRAND DISEASE: A SHORT HISTORY OF LABORATORY MILESTONES AND INNOVATIONS, PLUS CURRENT STATUS, CHALLENGES, AND SOLUTIONS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 40. ISSUE 5. P. 551 -570 | 104 | 97% | 4 |
8 | DE JONG, A , EIKENBOOM, J , (2016) DEVELOPMENTS IN THE DIAGNOSTIC PROCEDURES FOR VON WILLEBRAND DISEASE.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 14. ISSUE 3. P. 449 -460 | 75 | 97% | 3 |
9 | MURRAY, EW , LILLICRAP, D , (1996) VON WILLEBRAND DISEASE: PATHOGENESIS, CLASSIFICATION, AND MANAGEMENT.TRANSFUSION MEDICINE REVIEWS. VOL. 10. ISSUE 2. P. 93-110 | 157 | 94% | 15 |
10 | SADLER, JE , (1998) BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 67. ISSUE . P. 395-424 | 95 | 71% | 739 |
Classes with closest relation at Level 2 |